ArticleOncogene2025
SPTLC2 drives an EGFR-FAK-HBEGF signaling axis to promote ovarian cancer progression.
Xingyue Zhai et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
8 papers cite it
this papercites it
ArticleOncogene2025
Xingyue Zhai et al.PubMed ↗Publisher ↗
No numbers read from the abstract.